Contract: $799,786 - National Institutes of Health - Aug. 31, 2009
No votes have been cast for this award yet
Award Description: Recovery-ACTNOW Clinical Trial 8376 'Early Therapeutics Development with Phase II Emphasis'. Purpose: To allot American Recovery and Reinvestment Act (AA) funds for the ACTNOW project entitled 'A Randomized, Phase II Study of FOLFOX in Combination with Bezacizumab Plus or Minus GDC-0449 in Patients with Advanced Gastric Adenocarcinoma'.
Project Description: n/a
Jobs Summary: n/a (Total jobs reported: 0)
Project Status: Less Than 50% Completed
This award's data was last updated on Aug. 31, 2009. Help expand these official descriptions using the wiki below.